SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Drug Delivery: Top Headlines

Lonza to make heart failure gene therapy for Renova at Houston site

11-Feb-2016 - Lonza will make a candidate heart failure gene therapy for Renova Therapeutics under the second biomanufacturing deal it has signed this week.

Related news

News in brief

GSK is latest to assess VBI Vaccines' biologic stability tech after Sanofi

10-Feb-2016 - GSK will test a stability enhancement technology developed by VBI Vaccines in a deal announced this week.

Juniper to reformulate unpleasant tasting PharmAust cancer drug

08-Feb-2016 - Up to 90% of new chemical entities having properties that make them a challenge to successfully formulate, says Juniper Pharmaceuticals.

Sandoz teams with delivery tech firm MedinCell to get under the skin of cancer

04-Feb-2016 - Novartis subsidiary Sandoz will commercialise small and large molecule injectables using French delivery tech firm MedinCell’s subcutaneous controlled release platform.

MannKind sheds light on new $100m inhaled formulation partner

04-Feb-2016 - MannKind has spoken about Receptor Life Science, a newly-formed company which last month licensed the Technosphere inhaled delivery platform from the struggling firm.

Albumedix buys Eleven's half-life boosting albumin assets

29-Jan-2016 - Novozymes’ albumin technologies division Albumedix has bought Eleven Biotherapeutics’ half-life extension assets.

Could drug-loaded dental implants offer pain-free chronic med delivery?

27-Jan-2016 - Drug-loaded dental implants which release payload on-demand could alleviate invasive procedures associated with chronic diseases, scientists suggest.

Recipharm raises $32m to fund Nitin deal

27-Jan-2016 - Recipharm has raised SEK276m ($32m) to part finance the acquisition of a majority stake in Indian CMO Nitin Life Sciences that it announced in October.

Drug Delivery: Featured news

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...